drugset / Trial / NCT00595309

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595309

Phase 3 Completed 198 enrolled Valneva Austria GmbH
NaSingle-groupOpen-labelPrevention

Summary

The objective is to assess the effect of a booster vaccination on immunogenicity of IC51 in terms of seroconversion rate.

Timeline

Start
2007-12
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator IC51 Vaccine 6 ug Intramuscular

Indications